MODULATION OF HUNTINGTIN INTERACTING PROTEIN 2 EXPRESSION

Details for Australian Patent Application No. 2003297553 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors BENNETT, Frank, C.; DEAN, Nicholas, M.; DOBIE, Kenneth, W.

Pub. Number AU-A-2003297553

PCT Number PCT/US2003/0373

PCT Pub. Number WO2004/048522

Priority 10/303,292 23.11.02 US

Filing date 21 November 2003

Wipo publication date 18 June 2004

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 10/303,292 23.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-A-2003297553

25 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297554-MODULATION OF DEATH-ASSOCIATED PROTEIN KINASE 1 EXPRESSION

2003297552-ENZYME IMMOBILIZATION FOR USE IN BIOFUEL CELLS AND SENSORS